Cleared Traditional

K200731 - pjur AQUA Baseline, pjur AQUA Guarana, pjur AQUA ProVitamin B5, pjur BACK DOOR anal Provitamin B5 (FDA 510(k) Clearance)

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K200731 · Pjur Group Luxembourg S.A. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2021
Decision
307d
Days
Class 2
Risk

K200731 is an FDA 510(k) clearance for the pjur AQUA Baseline, pjur AQUA Guarana, pjur AQUA ProVitamin B5, pjur BACK DOO.... Classified as Lubricant, Personal (product code NUC), Class II - Special Controls.

Submitted by Pjur Group Luxembourg S.A. (Wasserbillig, LU). The FDA issued a Cleared decision on January 21, 2021 after a review of 307 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.5300 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Pjur Group Luxembourg S.A. devices

Submission Details

510(k) Number K200731 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 20, 2020
Decision Date January 21, 2021
Days to Decision 307 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
147d slower than avg
Panel avg: 160d · This submission: 307d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NUC Lubricant, Personal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.5300
Definition This Device Is A Personal Lubricant, For Penile And/or Vaginal Application, Intended To Moisturize And Lubricate, To Enhance The Ease And Comfort Of Intimate Sexual Activity, And Supplement The Body's Natural Lubrication. This Product May Or May Not Be Compatible With Natural Rubber Latex, Polyisoprene, And/or Polyurethane Condoms.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Candace F. Cederman
Candace Cederman

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - NUC Lubricant, Personal

All 239
Devices cleared under the same product code (NUC) and FDA review panel - the closest regulatory comparables to K200731.
Julva Velvé Water-Based Personal Lubricant
K254101 · Golden Isles Medical, Inc. · Apr 2026
Hyaluronic Acid Vaginal Suppository (HA 5 mg)
K260007 · Hudi Pharma Srl · Apr 2026
Water-based lubricant
K253983 · Guangzhou Haoyimai Trading Co., Ltd. · Mar 2026
Chiavaye Personal Moisturizer
K251011 · Unipack, LLC · Dec 2025
Hybrid personal lubricant (water&silicone) (5ml, 8ml, 10ml, 12ml, 15ml, 20ml, 30ml, 50ml, 60ml, 75ml, 90ml, 100ml, 120ml, 150ml, 180ml, 200ml, 250ml, 300ml, 500ml)
K252935 · Foshan Pingchuang Medical Technology Co., Ltd. · Dec 2025
Cerynë Intimate Care
K250488 · Ansella Therapeutics · Dec 2025